Pro-inflammatory cytokine levels in postmenopausal women with the metabolic syndrome

References

• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• AlbertiKG, ZimmetP, ShawJ. The metabolic syndrome – a new worldwide classification. Lancet 2005;366:1059–1062.
   PubMed Web of Science ®Google Scholar
• AlbertiKG, EckelRH, GrundySM, ZimmetPZ, CleemanJI, DonatoKA, FruchartJC, JamesWP, LoriaCM, SmithSC Jr. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• PichéME, WeisnagelSJ, CorneauL, NadeauA, BergeronJ, LemieuxS. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women. Diabetes 2005;54:770–777.
   PubMed Web of Science ®Google Scholar
• GustafsonB. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010;17:332–341.
   PubMed Web of Science ®Google Scholar
• Pérez-LópezFR, Larrad-MurL, KallenA, ChedrauiP, TaylorHS. Gender differences in cardiovascular disease: Hormonal and biochemical influences. Reprod Sci 2010;17:511–531.
   PubMed Web of Science ®Google Scholar
• FestaA, D'AgostinoRJ, HowardG, MykkänenL, RussellPT, HaffnerSM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42–47.
   PubMed Web of Science ®Google Scholar
• XuH, BarnesGT, YangQ, TanG, YangD, ChouCJ, SoleJ, NicholsA, RossJS, TartagliaLA, Chronic inflamma tion in fat plays a crucial role in the development of obesity- relates insulin resistance. J Clin Invest 2003;112:1821–1830.
   PubMed Web of Science ®Google Scholar
• WajchenbergBL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697–738.
   PubMed Web of Science ®Google Scholar
• ZiccardiP, NappoF, GiuglianoG, EspositoK, MarfellaR, CioffiM, D'AndreaF, MolinariAM, GiuglianoD. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804–809.
   PubMed Web of Science ®Google Scholar
• MauryE, BrichardSM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1–16.
   PubMed Web of Science ®Google Scholar
• HidalgoLA, ChedrauiPA, MorochoN, AlvaradoM, ChavezD, HucA. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 2006;22:447–454.
   PubMed Web of Science ®Google Scholar
• SitesCK, TothMJ, CushmanM, L'HommedieuGD, TchernofA, TracyRP, PoehlmanET. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 2002;77:128–135.
   PubMed Web of Science ®Google Scholar
• KosterA, StenholmS, AlleyDE, KimLJ, SimonsickEM, KanayaAM, VisserM, HoustonDK, NicklasBJ, TylavskyFA, for the Health ABC Study. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 2010, in press.
   Google Scholar
• SierraB, HidalgoLA, ChedrauiPA. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale. Maturitas 2005;51:236–245.
   PubMed Web of Science ®Google Scholar
• Castelo-BrancoC, BlümelJE, RoncaglioloME, HayaJ, BolfD, BinfaL, TaclaX, ColodrónM. Age, menopause and hormone replacement therapy influences on cardiovascular risk factors in a cohort of middle-aged Chilean women. Maturitas 2003;45:205–212.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services, Public Health Service, National Institutes of Health (NIH). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication No. 98–4080. Bethesda (MD): NIH; 1998.
   Google Scholar
• ChedrauiP, HidalgoL, ChavezD, MorochoN, AlvaradoM, HucA. Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas 2007;56:45–53.
   PubMed Web of Science ®Google Scholar
• BlumelJE, Castelo-BrancoC, BinfaL, GramegnaG, TaclaX, AracenaB, CumsilleMA, SanjuanA. Quality of life after the menopause: a population study. Maturitas 2000;34:17–23.
   PubMed Web of Science ®Google Scholar
• YouT, RyanAS, NicklasBJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 2004;89:5517–5522.
   PubMed Web of Science ®Google Scholar
• TankóLB, ChristiansenC. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy. Climacteric 2006;9:169–180.
   PubMed Web of Science ®Google Scholar
• PantsulaiaI, TrofimovS, KobylianskyE, LivshitsG. Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population. Cytokine 2002;19:138–146.
   PubMed Web of Science ®Google Scholar
• TedguiA, MallatZ. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006;86:515–581.
   PubMed Web of Science ®Google Scholar
• CantatoreFP, LoverroG, IngrossoAM, LacannaR, SassanelliE, SelvaggiL, CarrozzoM. Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause. Clin Rheumatol 1995;14:157–160.
   PubMed Web of Science ®Google Scholar
• CohenMC, CohenS. Cytokine function: a study in biologic diversity. Am J Clin Pathol 1996;105:589–598.
   PubMed Web of Science ®Google Scholar
• GirasoleG, GiulianiN, ModenaAB, PasseriG, PedrazzoniM. Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. Clin Endocrinol (Oxf) 1990;51:801–807.
   Google Scholar
• BrasierAR, LiJ, WimbishKA. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 1996;27:1009–1017.
   PubMed Web of Science ®Google Scholar
• KahalehMB, FanPS. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 1997;15:163–167.
   PubMed Web of Science ®Google Scholar
• PausovaZ, DeslauriersB, GaudetD, TremblayJ, KotchenTA, LarochelleP, CowleyAW, HametP. Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension 2000;36:14–19.
   PubMed Web of Science ®Google Scholar
• ZimmetP, MaglianoD, MatsuzawaY, AlbertiG, ShawJ. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005;12:295–300.
   PubMed Web of Science ®Google Scholar
• EspositoK, PontilloA, Di PaloC, GiuglianoG, MasellaM, MarfellaR, GiuglianoD. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799–1804.
   PubMed Web of Science ®Google Scholar
• StraubRH, HenseHW, AndusT, SchölmerichJ, RieggerGA, SchunkertH. Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab 2000;85:1340–1344.
   PubMed Web of Science ®Google Scholar
• YudkinJS, KumariM, HumphriesSE, Mohamed-AliV. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209–214.
   PubMed Web of Science ®Google Scholar
• BastardJP, MaachiM, LagathuC, KimMJ, CaronM, VidalH, CapeauJ, FeveB. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17:4–12.
   PubMed Web of Science ®Google Scholar
• DaneshJ, KaptogeS, MannAG, SarwarN, WoodA, AnglemanSB, WensleyF, HigginsJP, LennonL, EiriksdottirG, Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008;5:e78.
   PubMed Web of Science ®Google Scholar
• PradhanAD, MansonJE, RossouwJE, SiscovickDS, MoutonCP, RifaiN, WallaceRB, JacksonRD, PettingerMB, RidkerPM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002;288:980–987.
   PubMed Web of Science ®Google Scholar
• PradhanAD, MansonJE, RifaiN, BuringJE, RidkerPM. C- reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327–334.
   PubMed Web of Science ®Google Scholar
• StaessenJA, WangJ, BianchiG, BirkenhagerWH. Essential hypertension. Lancet 2003;361:1629–1641.
   PubMed Web of Science ®Google Scholar
• Vargas AlarcónG. Physiopathogenesis of hypertension. Arch Cardiol Mex 2006;76:157–160.
   Google Scholar
• BediM, VarshneyVP, BabbarR. Role of cardiovascular reactivity to mental stress in predicting future hypertension. Clin Exp Hypertens 2000;22:1–22.
   PubMed Web of Science ®Google Scholar
• BlackPH, GarbuttLD. Stress, inflammation and cardiovascular disease. J Psychosom Res 2002;52:1–23.
   PubMed Web of Science ®Google Scholar
• GrangerJP. An emerging role for inflammatory cytokines in hypertension. Am J Physiol Heart Circ Physiol 2006;290:H923–H924.
   PubMed Web of Science ®Google Scholar
• CohuetG, Struijker-BoudierH. Mechanisms of target organ damage caused by hypertension: Therapeutic potential. Pharmacol Ther 2006;111:81–98.
   PubMed Web of Science ®Google Scholar
• Roselló-LletíE, RiveraM, Martínez-DolzL, González JuanateyJR, CortésR, JordánA, MorillasP, LauwersC, CalabuigJR, AntorrenaI, Inflammatory activation and left ventricular mass in essential hypertension. Am J Hypertens 2009;22:444–450.
   PubMed Web of Science ®Google Scholar
• FrossardPM, GuptaA, PravicaV, PerreyC, HutchinsonIV, LukicML. A study of five human cytokine genes in human essential hypertension. Mol Immunol 2002;38:969–976.
   PubMed Web of Science ®Google Scholar
• BautistaLE, VeraLM, ArenasIA, GamarraG. Independent association between inflammatory markers (C-reactive protein, interleukin 6, and TNF-alpha) and essential hypertension. J Hum Hypertens 2005;19:149–154.
   PubMed Web of Science ®Google Scholar
• LeeDL, LeiteR, FlemingC, PollockJS, WebbRC, BrandsMW. Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice. Hypertension 2004;44:259–263.
   PubMed Web of Science ®Google Scholar
• Pöyhönen-AlhoMK, ManhemK, KatzmanP, KibarskisA, AntikainenRL, ErkkolaRU, TuomilehtoJO, EbelingPE, KaajaRJ. Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women. J Hypertens 2008;26:2445–2449.
   PubMed Web of Science ®Google Scholar
• FerreriNR. Estrogen-TNF interactions and vascular inflammation. Am J Physiol Heart Circ Physiol 2007;292:H2566–H2569.
   Web of Science ®Google Scholar
• MenteA, YusufS, IslamS, McQueenMJ, TanomsupS, OnenCL, RangarajanS, GersteinHC, AnandSS. Metabolic syndrome and risk of acute myocardial infarction. A case-control study of 26 903 subjects from 52 countries. J Am Coll Cardiol 2010;55:2390–2398.
   PubMed Web of Science ®Google Scholar
• The Heart Org. More evidence against concept of ‘metabolic syndrome’. Available from: http://www.theheart.org/article/1080363.do [Accessed June 30, 2010].
   Google Scholar
• Leal HernándezM, Abellán AlemánJ, Carbonell MeseguerLF, Díaz FernándezJ, García SánchezFA, Martínez SelvaJM. Influence of the presence of hot flashes during menopause on the metabolism of nitric oxide. Effects of hormonal replacement treatment. Med Clin (Barc) 2000;114:41–45.
   PubMed Web of Science ®Google Scholar
• GambaccianiM, PepeA. Vasomotor symptoms and cardiovascular risk. Climacteric 2009;12(Suppl 1):32–35.
   PubMed Web of Science ®Google Scholar
• ChedrauiP, HidalgoL, ChavezD, MorochoN, AlvaradoM, HucA. Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndrome. Arch Gynecol Obstet 2007;275:161–168.
   PubMedGoogle Scholar
• Pérez-LópezFR, ChedrauiP, GilbertJJ, Pérez-RonceroG. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: Facing the post-WHI era. Fertil Steril 2009;92:1171–1188.
   PubMed Web of Science ®Google Scholar
• ThurstonRC, KullerLH, EdmundowiczD, MatthewsKA. History of hot flashes and aortic calcification among postmenopausal women. Menopause 2010;17:256–261.
   PubMed Web of Science ®Google Scholar
• NoguchiM, YuzuriharaM, KaseY, YasuiT, IraharaM. Involvement of cytokine-induced neutrophil chemoattractant in hypothalamic thermoregulation of luteinizing hormone-releasing hormone. Endocrinology 2008;149:2899–2906.
   PubMed Web of Science ®Google Scholar
• YasuiT, UemuraH, TomitaJ, MiyataniY, YamadaM, KuwaharaA, MatsuzakiT, MaegawaM, TsuchiyaN, YuzuriharaM, Association of interleukin-8 with hot flashes in premenopausal, perimenopausal, and postmenopausal women and bilateral oophorectomized women. J Clin Endocrinol Metab 2006;91:4805–4808.
   PubMed Web of Science ®Google Scholar
• YasuiT, MaegawaM, TomitaJ, MiyataniY, YamadaM, UemuraH, UenoS, NumataS, OhmoriT, TsuchiyaN, Association of serum cytokine concentrations with psychological symptoms in midlife women. J Reprod Immunol 2007;75:56–62.
   PubMed Web of Science ®Google Scholar